Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines
Clinical trial NCT04763265 · COMPLETED
Trial details
- NCT number
- NCT04763265
- Sponsor
- Croma-Pharma GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-24
- Primary completion
- 2020-11-05
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.